Estetrol (E4) is emerging as a novel estrogen with unique pharmacologic properties and potential clinical advantages. In this evidence-based session, Dr. Mitch Creinin will explore the science behind E4, including its mechanism of action, safety profile, and clinical applications in contraception and menopausal hormone therapy. Attendees will gain insight into how E4 differs from traditional estrogens and where it may fit in future prescribing practices.

Mitchell D. Creinin, MD, is a board-certified obstetrician-gynecologist and Professor of Obstetrics and Gynecology at the University of California, Davis. A leading expert in family planning and contraceptive research, Dr. Creinin has authored over 200 peer-reviewed publications and has played a pivotal role in shaping national guidelines on contraception and abortion care. His work focuses on expanding access to reproductive health services through evidence-based practice and policy.